Logo image of OTLK

OUTLOOK THERAPEUTICS INC (OTLK) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:OTLK - US69012T3059 - Common Stock

0.5222 USD
-0.02 (-3.3%)
Last: 1/15/2026, 8:05:43 PM
0.5201 USD
0 (-0.4%)
After Hours: 1/15/2026, 8:05:43 PM
Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to OTLK. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 9.69. This target is 1755.61% above the current price.
  • OTLK was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about OTLK.
  • In the previous month the buy percentage consensus was at a similar level.
  • OTLK was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
OTLK Historical Analyst RatingsOTLK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -101 -92 -83 -74 -65 -56 -47 -38 -29 -20 -11 -2 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.521.018.169.6922.05 - 93.41% 1,462.62% 1,755.61% 4,122.52%
OTLK Current Analyst RatingOTLK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2026-01-05 Chardan Capital Maintains Neutral -> Neutral
2026-01-02 HC Wainwright & Co. Maintains Neutral -> Neutral
2025-12-22 Ascendiant Capital Maintains Buy -> Buy
2025-09-30 HC Wainwright & Co. Reiterate Neutral -> Neutral
2025-09-22 Ascendiant Capital Maintains Buy -> Buy
2025-08-29 Guggenheim Downgrade Buy -> Neutral
2025-08-29 HC Wainwright & Co. Downgrade Buy -> Neutral
2025-08-28 Chardan Capital Maintains Neutral -> Neutral
2025-08-15 Chardan Capital Maintains Neutral -> Neutral
2025-06-06 Ascendiant Capital Maintains Buy -> Buy
2025-02-24 Ascendiant Capital Maintains Buy -> Buy
2025-02-18 Chardan Capital Maintains Neutral -> Neutral
2025-02-18 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-17 Guggenheim Reiterate Buy -> Buy
2025-01-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-02 Chardan Capital Downgrade Buy -> Neutral
2024-11-29 BTIG Maintains Buy -> Buy
2024-11-29 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-18 BTIG Reiterate Buy -> Buy
2024-09-03 Ascendiant Capital Maintains Buy -> Buy
2024-08-16 Chardan Capital Maintains Buy -> Buy
2024-08-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-27 BTIG Upgrade Neutral -> Buy
2024-03-25 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-15 Chardan Capital Upgrade Neutral -> Buy
2024-01-25 Brookline Capital Upgrade Hold -> Buy
2024-01-25 Guggenheim Upgrade Neutral -> Buy
2023-12-29 Ascendiant Capital Maintains Buy -> Buy
2023-12-27 Capital One Upgrade Equal-Weight -> Overweight

OUTLOOK THERAPEUTICS INC / OTLK FAQ

What is the average price target for OUTLOOK THERAPEUTICS INC (OTLK) stock?

11 analysts have analysed OTLK and the average price target is 9.69 USD. This implies a price increase of 1755.61% is expected in the next year compared to the current price of 0.5222.


How do analysts rate OUTLOOK THERAPEUTICS INC (OTLK)?

The consensus rating for OUTLOOK THERAPEUTICS INC (OTLK) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.